🇺🇸 FDA
Patent

US 7544778

Recombinant antigens for diagnosis and prevention of murine typhus

granted A61KA61K39/0233A61P

Quick answer

US patent 7544778 (Recombinant antigens for diagnosis and prevention of murine typhus) held by United States of America as represented by the Secretary of the Air Force expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K39/0233, A61P, A61P31/04